首页> 外文期刊>Japanese Journal of Cancer Research >Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination.
【24h】

Chemoprevention of N-nitroso-N-methylurea-induced rat mammary cancer by miso and tamoxifen, alone and in combination.

机译:味mis和他莫昔芬单独或组合化学预防N-亚硝基-N-甲基脲诱导的大鼠乳腺癌。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

We examined the effects of a Japanese fermented soybean product, miso, and tamoxifen (TAM), alone and in combination, on N-nitroso-N-methylurea (MNU)-induced rat mammary cancer. Seven-week-old female CD/Crj rats received a single i.v. dose (50 mg/kg body weight) of MNU. After administration of MNU, the rats were divided into 4 groups: regular diet (control), 10% miso diet, regular diet + TAM, and 10% miso diet + TAM. TAM was implanted s.c. in the form of pellets containing 2.5 mg at the same time as MNU was administered. All rats were observed for 18 weeks after MNU administration. Incidence (percentage of rats with tumors) and multiplicity (mean tumors/rat) of mammary tumors were 91% and 4.5 in the control, 77% and 2.4 (P < 0.05) in the 10% miso group, 68% and 1.4 (P <0.01) in the TAM group, and 10% (P < 0.0001 or less) and 0.2 (P < 0.0001) in the 10% miso + TAM group. In the second experiment, the effect of the combination of miso and TAM on established rat mammary tumors was investigated. When the mammary tumors induced by MNU reached 10 to 25 mm, the rats were divided into 3 treatment groups: regular diet, regular diet + TAM, and 10% miso diet + TAM. At 6 weeks after the start of treatment, the mean tumor size in the control and TAM groups was 160% and 141% of the pretreatment value, but a decrease of 85% of the pretreatment value was produced by the combination of miso and TAM, and this was significantly different from both the control and TAM groups (P < 0.01) and P < 0.05, respectively). These results indicate that miso is useful in protecting against mammary cancer and it can be expected to have a potent antitumor effect, especially when used in combination with TAM.
机译:我们研究了单独和组合使用日本发酵大豆产品味mis和他莫昔芬(TAM)对N-亚硝基-N-甲基脲(MNU)诱导的大鼠乳腺癌的影响。七周大的雌性CD / Crj大鼠接受了一次静脉注射。剂量(50 mg / kg体重)的MNU。施用MNU后,将大鼠分为4组:常规饮食(对照组),10%味mis饮食,常规饮食+ TAM和10%味o饮食+ TAM。 TAM被植入s.c.在服用MNU的同时服用2.5毫克的小丸形式。 MNU给药后观察所有大鼠18周。乳腺肿瘤的发生率(患肿瘤的百分数)和乳腺肿瘤的多重性(平均肿瘤/大鼠)在对照组中分别为91%和4.5,在10%味o组中分别为77%和2.4(P <0.05),68%和1.4(P TAM组为<0.01),10%味+ + TAM组为10%(P <0.0001或更低)和0.2(P <0.0001)。在第二个实验中,研究了味o和TAM组合对已建立的大鼠乳腺肿瘤的影响。当MNU诱导的乳腺肿瘤达到10至25 mm时,将大鼠分为3个治疗组:常规饮食,常规饮食+ TAM和10%味o饮食+ TAM。在开始治疗后的第6周,对照组和TAM组的平均肿瘤大小分别为治疗前值的160%和141%,但味mis和TAM的组合会使治疗前值降低了85%,与对照组和TAM组均存在显着差异(分别为P <0.01)和P <0.05)。这些结果表明,味o可用于预防乳癌,并且有望具有强大的抗肿瘤作用,尤其是与TAM组合使用时。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号